Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

59°
- Newton, NC (28658)
  Today
  
  Rain ending this morning. Sunshine breaking out this afternoon. Near record high temperatures. High 78F. Winds W at 10 to 20 mph. Chance of rain 80%..
  
  Tonight
  
  Partly cloudy skies this evening will become overcast overnight. Slight chance of a rain shower. Low 53F. Winds WNW at 5 to 10 mph.
  
  Updated: February 20, 2026 @ 8:30 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
e-Edition
Best of 2025
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

843.98 -3.28 (-0.39%)

Streaming Delayed Price Updated: 9:54 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about argenx SE - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Top AI Stock ANET Leads 5 Stocks Near Buy Points In Tough Market ↗

August 19, 2023

Arista Networks and Dutch biotech Argenx lead this weekend's watch list.

Via Investor's Business Daily

Topics Artificial Intelligence

Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗

August 10, 2023

Via Benzinga

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗

July 31, 2023

Via Benzinga

Is Argenx Stock a Buy Now? ↗

July 31, 2023

Good news keeps rolling in for the biotech.

Via The Motley Fool

Earnings Outlook For argenx ↗

July 26, 2023

Via Benzinga

Argenx Stock Rides 'Megabuster' Drug Excitement To 40% Gain Before Earnings ↗

July 26, 2023

Argenx is up around 40% in 2023 after shares soared nearly 30% in a single day last week.

Via Investor's Business Daily

argenx Unusual Options Activity ↗

July 21, 2023

Via Benzinga

Why Shares of Argenx Jumped This Week ↗

July 21, 2023

The company's lead therapy showed progress in treating an autoimmune disorder.

Via The Motley Fool

The Latest Analyst Ratings for argenx ↗

July 20, 2023

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today ↗

July 18, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗

July 21, 2023

But all the major indexes are at or near 15-month highs.

Via Investor's Business Daily

Why Argenx Stock Is on Fire Today ↗

July 17, 2023

A major clinical win is boosting the drugmaker's shares today.

Via The Motley Fool

Why Is Argenx (ARGX) Stock Up 27% Today? ↗

July 17, 2023

Argenx (ARGX) stock is climbing higher on Monday following the release of data from a Phase 1 clinical trial of VYVGART Hytrulo.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade ↗

July 20, 2023

On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.

Via Investor's Business Daily

Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development ↗

July 18, 2023

Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 17, 2023

Via Benzinga

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

Argenx Catapults 27% To Record High As It Edges Closer To A New Multibillion-Dollar Market ↗

July 17, 2023

Vyvgart is already approved in multiple diseases. But Argenx isn't stopping there.

Via Investor's Business Daily

You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers ↗

July 17, 2023

Big gains are afoot even as the markets prepare for a flat open.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 17, 2023

Via Benzinga

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2023

Gainers

Via Benzinga

Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today? ↗

July 17, 2023

BYND Cannasoft Enterprise (BCAN) stock is dropping on Monday after the company announced an underwritten stock offering.

Via InvestorPlace

Why Are Argenx Shares Trading Higher Today? ↗

July 17, 2023

Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory

Via Benzinga

Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today? ↗

July 17, 2023

Quoin Pharmaceuticals (QNRX) stock is taking a massive beating on Monday as the company prepares for an ADS ratio change.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 17, 2023

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

Via InvestorPlace

Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

July 17, 2023

U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

This Emerging Market Could Be the Next Big Thing in Biotech ↗

July 14, 2023

Medicines to treat the many symptoms of long COVID are in high demand already.

Via The Motley Fool

Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration ↗

July 08, 2023

F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic...

Via Talk Markets

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
e-Edition
Announcements
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Calendar
Email Alerts
Search
Weather

Contact Information

ObserverNewsOnline.com
309 North College Avenue
Newton, NC 28658
Phone: 828-464-0221
Email: admanager@observernewsonline.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Newton, NC (28658)

Today

Tonight

argenx SE - American Depositary Shares (NQ:ARGX)

Headline News about argenx SE - American Depositary Shares

Sections

Services

Contact Information

Follow Us